Medical treatment for ocular surface squamous neoplasia.
Monroy D, Serrano A, Galor A, Karp CL.
Eye (Lond). 2023 Apr;37(5):885-893. doi: 10.1038/s41433-023-02434-x. Epub 2023 Feb 8.
Updates in Ocular Surface Tumor Diagnostics.
Nanji AA, Mercado C, Galor A, Dubovy S, Karp CL.
Int Ophthalmol Clin. 2017 Summer;57(3):47-62. doi: 10.1097/IIO.0000000000000174.
Ocular Surface Fibroma: A Rare, Benign Tumor of the Conjunctiva.
Weppelmann TA, Margo CE, Espana EM.
Ophthalmology. 2025 Feb;132(2):e31. doi: 10.1016/j.ophtha.2024.02.020. Epub 2024 Mar 23.
[Ocular surface squamous neoplasia].
Tóth G, Sándor GL, Gyenes A, Tóth J, Seitz B, Nagy ZZ, Szentmáry N.
Orv Hetil. 2017 Dec;158(51):2011-2022. doi: 10.1556/650.2017.30939.
Cancers of the eye.
Maheshwari A, Finger PT.
Cancer Metastasis Rev. 2018 Dec;37(4):677-690. doi: 10.1007/s10555-018-9762-9.
Ocular surface toxicities associated with modern anticancer therapies.
Boucher R, Haigh O, Barreau E, Champiat S, Lambotte O, Adam C, Labetoulle M, Rousseau A.
Surv Ophthalmol. 2024 Mar-Apr;69(2):198-210. doi: 10.1016/j.survophthal.2023.10.002. Epub 2023 Oct 6.
Update in ocular surface squamous neoplasia.
Novelli A, Romero-Kusabara IL, Frazão MAM.
Rev Assoc Med Bras (1992). 2024 Jun 7;70(suppl 1):e2024S124. doi: 10.1590/1806-9282.2024S124. eCollection 2024.
Supportive treatment to chemotherapy with MMC, in patients with ocular surface squamous neoplasia or conjunctival melanocytic tumor.
Sammarco MG, Pagliara MM, Savino G, Giannuzzi F, Carlà MM, Caputo CG, Blasi MA.
J Cancer Res Clin Oncol. 2023 Jul;149(8):4305-4314. doi: 10.1007/s00432-022-04241-5. Epub 2022 Sep 8.
Ocular Surface Squamous Neoplasia Masqueraders.
Mercado C, Parra-Rosas C, Karp CL.
Semin Ophthalmol. 2026 Feb;41(2):331-341. doi: 10.1080/08820538.2025.2548021. Epub 2025 Aug 26.
Ocular surface complications of local anticancer drugs for treatment of ocular tumors.
Moon J, Choi SH, Lee MJ, Jo DH, Park UC, Yoon SO, Woo SJ, Oh JY.
Ocul Surf. 2021 Jan;19:16-30. doi: 10.1016/j.jtos.2020.11.006. Epub 2020 Nov 22.
